Elevance Health Balance Sheet Health
Financial Health criteria checks 4/6
Elevance Health has a total shareholder equity of $41.4B and total debt of $31.2B, which brings its debt-to-equity ratio to 75.4%. Its total assets and total liabilities are $116.7B and $75.2B respectively. Elevance Health's EBIT is $10.1B making its interest coverage ratio 8.5. It has cash and short-term investments of $34.7B.
Key information
75.4%
Debt to equity ratio
US$31.23b
Debt
| Interest coverage ratio | 8.5x |
| Cash | US$34.68b |
| Equity | US$41.43b |
| Total liabilities | US$75.25b |
| Total assets | US$116.67b |
Recent financial health updates
Elevance Health (NYSE:ELV) Seems To Use Debt Rather Sparingly
Nov 30
Is Elevance Health (NYSE:ELV) Using Too Much Debt?
Apr 16Recent updates
Elevance Health: Trading At Depressed Levels, So We Added Modestly
Jan 30Elevance Health (NYSE:ELV) Will Pay A Larger Dividend Than Last Year At $1.71
Jan 26Elevance Health Q4 2024 Earnings: Managed Care Continues To Impress
Jan 23Is There Now An Opportunity In Elevance Health, Inc. (NYSE:ELV)?
Jan 15Elevance Health Is An Undervalued Healthcare Juggernaut
Dec 26Returns Are Gaining Momentum At Elevance Health (NYSE:ELV)
Dec 15Elevance Health: A Quality Underpriced Stock Returning To Health
Dec 11Elevance Health (NYSE:ELV) Seems To Use Debt Rather Sparingly
Nov 30We Think Elevance Health's (NYSE:ELV) Profit Is Only A Baseline For What They Can Achieve
Oct 29Elevance Health: A Bad Q3 Was Almost Inevitable Given Industry Headwinds
Oct 17Elevance: Our Top Value Pick Trading At 12.5x Earnings And Growing At 12.5%
Oct 10Is Now An Opportune Moment To Examine Elevance Health, Inc. (NYSE:ELV)?
Oct 08Investors Continue Waiting On Sidelines For Elevance Health, Inc. (NYSE:ELV)
Sep 11Elevance Health: Strong Earnings Growth Supports Strong Dividend Growth
Sep 06There's Been No Shortage Of Growth Recently For Elevance Health's (NYSE:ELV) Returns On Capital
Aug 29Here's Why We Think Elevance Health (NYSE:ELV) Is Well Worth Watching
Aug 02Elevance Health: Healthcare Services Segment Is Gaining Traction
Jul 31Elevance Health: Buy A Dividend Growth Machine
Jul 18Elevance Health: Favorable Trends Are Emerging (Rating Upgrade)
Jun 28Is Now An Opportune Moment To Examine Elevance Health, Inc. (NYSE:ELV)?
Jun 11Elevance Health's (NYSE:ELV) Returns On Capital Are Heading Higher
May 27We Think Shareholders Will Probably Be Generous With Elevance Health, Inc.'s (NYSE:ELV) CEO Compensation
May 09Elevance Health (NYSE:ELV) Has Announced A Dividend Of $1.63
Apr 25Elevance Health: It's Not Too Late To Buy Their Dividend Growth
Apr 23Is Elevance Health (NYSE:ELV) Using Too Much Debt?
Apr 16Elevance Health: Not Doing Enough In 2024 To Justify Premium Price
Apr 11Elevance Health, Inc.'s (NYSE:ELV) Earnings Haven't Escaped The Attention Of Investors
Apr 01Elevance: A Healthy Dose Of Dividend Growth
Mar 21Elevance Heath: Financial Growth And Technical Strength Indicate A Buy
Mar 07Elevance Health (NYSE:ELV) Will Pay A Larger Dividend Than Last Year At $1.63
Feb 19Elevance Health: Time To Buy This Incredible Dividend Growth Stock
Jan 26A Look At Elevance's Margin Dynamics
Nov 23Elevance Health: A High Conviction Defensive Blue Chip Buy
Oct 19Elevance: Pave The Way For The Next UnitedHealth
Sep 21Here's The Price I Would Buy Elevance Health Stock
Sep 13Financial Position Analysis
Short Term Liabilities: ELV's short term assets ($58.7B) exceed its short term liabilities ($40.4B).
Long Term Liabilities: ELV's short term assets ($58.7B) exceed its long term liabilities ($34.9B).
Debt to Equity History and Analysis
Debt Level: ELV has more cash than its total debt.
Reducing Debt: ELV's debt to equity ratio has increased from 63.3% to 75.4% over the past 5 years.
Debt Coverage: ELV's debt is not well covered by operating cash flow (18.6%).
Interest Coverage: ELV's interest payments on its debt are well covered by EBIT (8.5x coverage).
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/02/07 06:41 |
| End of Day Share Price | 2025/02/07 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Elevance Health, Inc. is covered by 48 analysts. 14 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Jasper Hellweg | Argus Research Company |
| Hua Ha | Baird |
| Ishan Majumdar | Baptista Research |